DPH.L - Dechra Pharmaceuticals plc

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Currency in GBp

Valuation measures4

Market cap (intra-day) 4.24B
Enterprise value 4.66B
Trailing P/E 104.12
Forward P/E 29.59
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.73
Price/book (mrq)5.05
Enterprise value/revenue 6.41
Enterprise value/EBITDA 27.61

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3-13.45%
S&P500 52-week change 31.77%
52-week high 33,882.00
52-week low 331.08
50-day moving average 33,217.56
200-day moving average 32,945.71

Share statistics

Avg vol (3-month) 31.17M
Avg vol (10-day) 31.21M
Shares outstanding 5113.88M
Implied shares outstanding 6N/A
Float 8112.54M
% held by insiders 10.88%
% held by institutions 188.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.45
Forward annual dividend yield 41.43%
Trailing annual dividend rate 30.45
Trailing annual dividend yield 30.01%
5-year average dividend yield 41.08
Payout ratio 4125.11%
Dividend date 3N/A
Ex-dividend date 409 Mar 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 5.52%
Operating margin (ttm)11.74%

Management effectiveness

Return on assets (ttm)3.65%
Return on equity (ttm)5.42%

Income statement

Revenue (ttm)726.8M
Revenue per share (ttm)6.56
Quarterly revenue growth (yoy)13.50%
Gross profit (ttm)384.8M
Net income avi to common (ttm)40.1M
Diluted EPS (ttm)0.35
Quarterly earnings growth (yoy)-44.50%

Balance sheet

Total cash (mrq)87.9M
Total cash per share (mrq)0.78
Total debt (mrq)511.2M
Total debt/equity (mrq)60.73
Current ratio (mrq)2.73
Book value per share (mrq)7.44

Cash flow statement

Operating cash flow (ttm)86.3M
Levered free cash flow (ttm)18.79M